Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program.
about
Recent Advances in the Diagnosis and Treatment of Clostridium Difficile InfectionUltrasensitive Detection and Quantification of Toxins for Optimized Diagnosis of Clostridium difficile InfectionRisk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic reviewClostridium difficile: A healthcare-associated infection of unknown significance in adults in sub-Saharan AfricaClostridium difficile Infection in Pediatric Inflammatory Bowel DiseaseClostridium difficile infection in inflammatory bowel disease: challenges in diagnosis and treatment.New concepts in diagnostics for infectious diarrhea.Lack of Association Between the Clinical Outcome of Clostridium difficile Infection and Current Steroids Use.Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study.Epidemiology of Clostridium difficile infectionEmerging technologies for the clinical microbiology laboratory.Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 Update.Estimating risk of C. difficile transmission from PCR positive but cytotoxin negative cases.Comparison of the Vidas C. difficile GDH Automated Enzyme-Linked Fluorescence Immunoassay (ELFA) with Another Commercial Enzyme Immunoassay (EIA) (Quik Chek-60), Two Selective Media, and a PCR Assay for gluD for Detection of Clostridium difficile inEvaluating the Effectiveness of an Antimicrobial Stewardship Program on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection: A Non-Randomized, Stepped Wedge, Single-Site, Observational Study.Usefulness of Adjunctive Fecal Calprotectin and Serum Procalcitonin in Individuals Positive for Clostridium difficile Toxin Gene by PCR Assay.Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in Barcelona, Spain.Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1/027.Clostridium difficile infection in a French university hospital: Eight years of prospective surveillance study.Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.Elevated fecal calprotectin associates with adverse outcomes from Clostridium difficile infection in older adults.Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infectionVariability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID)Clinical update for the diagnosis and treatment of Clostridium difficile infection.Impact of change to molecular testing for Clostridium difficile infection on healthcare facility-associated incidence rates.Variations in virulence and molecular biology among emerging strains of Clostridium difficile.Molecular methods in the diagnosis of Clostridium difficile infections: an update.Comparison of Simplexa universal direct PCR with cytotoxicity assay for diagnosis of Clostridium difficile infection: performance, cost, and correlation with disease.Diagnosis of Clostridium difficile infection: the molecular approach.Real-time cellular analysis for quantitative detection of functional Clostridium difficile toxin in stool.The prevalence of Clostridium difficile infection in pediatric and adult patients with inflammatory bowel disease.Challenges and opportunities in the management of Clostridium difficile infection.Clostridium difficile infection: epidemiology, diagnosis and understanding transmission.Effect of Clostridium difficile Prevalence in Hospitals and Nursing Homes on Risk of Infection.Clostridium difficile Infections in Children: Impact of the Diagnostic Method on Infection Rates.Optimizing the diagnostic testing of Clostridium difficile infection.Rapid detection of Clostridium difficile toxins and laboratory diagnosis of Clostridium difficile infections.Inappropriate Clostridium difficile Testing and Consequent Overtreatment and Inaccurate Publicly Reported Metrics.
P2860
Q26766112-92BD184D-853B-4AED-B104-377A0792847AQ26776411-B59A4DD7-3B4F-4845-BCDC-C7716DC042F9Q27021390-3F30B31A-D5B2-4AAC-B73F-0104EAE6A188Q28077618-77DDFF05-F5D0-4215-A2F8-C3C3E2E83CB1Q28080494-8FC93EB1-727A-4862-AF6C-E63002B25AD6Q30235905-F81E8153-0E4B-48F8-8B23-BF9A63739C1DQ30456827-8D450C09-63D2-4B7F-AF92-5B5FC78BE0F2Q33625264-55E9E968-3236-4076-8F90-CF3732E71047Q33831557-0BE79BBD-92C4-462B-A589-E9AC7E4EE5BDQ34027474-549305ED-C46C-45B7-9470-5E8BBA9C3A14Q34297668-3E93A183-F9EF-46BA-B1BA-AE4B00E63AE5Q34419009-63DC072D-A00A-4917-A0A3-0129FC968BF8Q35093580-87D607A3-8BCD-4DDE-A7BF-9FAD46C904B5Q35607512-BD25B524-4B92-4250-A74E-8F27475614A5Q36053985-8208D54D-3C6D-418E-B950-F125AD818CADQ36173931-1CB0A4F1-603B-43DD-9862-7F63EFADE8F1Q36667575-3D1FED06-FD67-409D-B0AB-0BE94CD3E8C2Q36826679-41FFD197-1055-4291-9E0A-E23FAB920E78Q36856267-6F2FC59A-E12D-47FF-8614-DCF44A5D8CA7Q37003725-160DF874-A151-4756-A761-4F85239C2802Q37035829-53C9DE82-5CB1-415A-A90A-CACC0E60759CQ37103258-BAA338AF-B0F4-4A80-BDA1-DF20FFA9FAD0Q37109212-568298D9-09E4-4CDC-8B37-D1D045F6040AQ37293591-5E873CD2-A109-42F3-89FE-135F6EC4E7E5Q37475243-2079D1F0-59B0-46C2-B5F0-C10D89103279Q37633859-CB8A2ADE-6B9D-42FE-A0AB-6FFAE974685BQ37667082-8195FF7B-0486-4D1F-AE7E-C19CF94610E1Q37680481-CF2A4FE1-5D0E-40AA-95EF-B8F178A3D4E9Q38142247-2285B8E4-4E87-4D1B-A720-D00444C0DE1EQ38162391-50C945A3-9968-41EE-A313-20F990FA1544Q38165197-CF111F24-2BAA-40C0-AEB0-C52AA2262251Q38197671-9CA30595-ED8B-4EF3-91B6-C7CBCF6DD2E5Q38208694-79CEDAF0-7BD9-49FC-A412-3585CC34672EQ38228162-BA4F2BCE-F7E5-4FCC-A37F-C10C1C14B37FQ38765888-1BBAE7D6-322A-4BC9-A4AA-C3ADEC287101Q38844534-EA8B2A1A-BB23-4C01-8734-58F5E6B1C3F8Q38855394-06871D3B-1C99-45ED-BA8C-CA0483122478Q38909959-0AC2811E-A3B0-4FAD-A1D7-984788BF41CAQ38947888-EC376388-376C-4D38-B445-95864E1B4E19Q38964033-9BF0C2ED-551E-4D90-B438-8359B43D2164
P2860
Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Impact of the type of diagnost ...... a mandatory reporting program.
@en
Impact of the type of diagnost ...... a mandatory reporting program.
@nl
type
label
Impact of the type of diagnost ...... a mandatory reporting program.
@en
Impact of the type of diagnost ...... a mandatory reporting program.
@nl
prefLabel
Impact of the type of diagnost ...... a mandatory reporting program.
@en
Impact of the type of diagnost ...... a mandatory reporting program.
@nl
P2093
P2860
P356
P1476
Impact of the type of diagnost ...... a mandatory reporting program.
@en
P2093
Bianka Paquet-Bolduc
Catherine Beaulieu
Christophe Garenc
Danielle Goulet
Gilles Brochu
Jean Longtin
Vilayvong Loungnarath
Yves Longtin
P2860
P356
10.1093/CID/CIS840
P407
P577
2012-09-25T00:00:00Z